NCT02915809View on ClinicalTrials.gov

A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults

PHASE3UnknownINTERVENTIONAL
Enrollment

414

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

May 31, 2017

Conditions
Influenza, Human
Interventions
BIOLOGICAL

GC3110B vaccine

0.5mL, Intramuscular

BIOLOGICAL

GCFLU Quadrivalent Inj. vaccine

0.5mL, Intramuscular

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY